Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19012840 | POLYSACCHARIDE COMPOUND WITH A DEFINED MOLECULAR STRUCTURE THAT CAN ELIMINATE THE TOXIC SIDE EFFECTS OF CHEMOTHERAPY DRUGS | January 2025 | June 2025 | Allow | 5 | 0 | 1 | Yes | No |
| 18972246 | TRADITIONAL CHINESE HERBAL COMPOSITION FOR TREATMENT OF BACTERIAL VAGINOSIS AND PREPARATION METHOD THEREOF | December 2024 | February 2025 | Allow | 2 | 0 | 0 | No | No |
| 18948016 | PEONY STAMEN-DODDER COMPOSITE, AND ITS PREPARATION METHOD AND APPLICATION | November 2024 | January 2025 | Allow | 2 | 0 | 0 | Yes | No |
| 18942174 | PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA | November 2024 | May 2025 | Allow | 6 | 1 | 0 | No | No |
| 18934450 | ESSENTIAL OIL OF STEMS AND LEAVES OF CHUZHOU CHRYSANTHEMUM AND APPLICATION THEREOF | November 2024 | March 2025 | Allow | 4 | 0 | 1 | No | No |
| 18926515 | GAME ATTRACTANT AND VARMINT REPELLENT COMPOSITIONS AND METHODS | October 2024 | March 2025 | Allow | 5 | 1 | 1 | Yes | No |
| 18911447 | MEDICINAL MUSHROOM-BASED TOPICAL COMPOSITION | October 2024 | January 2025 | Allow | 4 | 1 | 1 | Yes | No |
| 18907606 | ANTIBACTERIAL MODIFIED CHITOSAN-BASED HEMOSTATIC MATERIAL AND METHOD OF MANUFACTURING THE SAME | October 2024 | January 2025 | Allow | 3 | 0 | 1 | No | No |
| 18894385 | COMPOSITION FOR WEIGHT REDUCTION AND BODY FAT REDUCTION, PREPARATION METHOD AND APPLICATION THEREOF | September 2024 | April 2025 | Allow | 6 | 1 | 1 | No | No |
| 18844892 | METHOD FOR IMPROVING HEALTH CONDITION OF MAMMAL OR FARM ANIMAL | September 2024 | February 2025 | Allow | 5 | 0 | 0 | No | No |
| 18818636 | CHITOSAN COMPOSITION AND METHOD OF MANUFACTURING THE SAME | August 2024 | November 2024 | Allow | 2 | 0 | 0 | No | No |
| 18806538 | METHODS OF INHIBITING CANCER GROWTH AND INHIBITING VIRAL INFECTIONS | August 2024 | April 2025 | Allow | 8 | 1 | 1 | Yes | No |
| 18796479 | Curcuminoid composition of Curcumin-keto, method of preparation and use thereof | August 2024 | November 2024 | Allow | 3 | 1 | 0 | Yes | No |
| 18794793 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME | August 2024 | January 2025 | Allow | 5 | 0 | 1 | Yes | No |
| 18773936 | OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOF | July 2024 | May 2025 | Allow | 10 | 0 | 1 | No | No |
| 18764014 | FORMULATIONS AND METHODS FOR SKIN CARE | July 2024 | December 2024 | Allow | 5 | 1 | 1 | Yes | No |
| 18757390 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | June 2024 | December 2024 | Allow | 5 | 1 | 0 | No | No |
| 18750691 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | June 2024 | March 2025 | Allow | 9 | 2 | 1 | No | No |
| 18746153 | MUNG BEAN HULL EXTRACT WITH ANTIVIRAL EFFECT AND EXTRACTION METHOD THEREOF | June 2024 | April 2025 | Allow | 10 | 0 | 1 | No | No |
| 18745674 | COMPOSITIONS AND METHOD FOR TREATING AND PREVENTING COMPLICATIONS OF OBESITY | June 2024 | April 2025 | Allow | 10 | 1 | 1 | No | No |
| 18736592 | TRADITIONAL CHINESE MEDICINE COMPOUND FOR PREVENTING AND TREATING AFRICAN SWINE FEVER, AND ITS EFFICIENCY ENHANCEMENT PROCESS AND APPLICATION | June 2024 | October 2024 | Allow | 5 | 0 | 1 | No | No |
| 18736009 | PEST CONTROL USING NATURAL PEST CONTROL AGENT BLENDS | June 2024 | January 2025 | Allow | 8 | 2 | 1 | Yes | No |
| 18733907 | URINARY SYSTEM CATHETER USING ETHANOL EXTRACT OF PROPOLIS AS COATING AND PREPARATION METHOD THEREOF | June 2024 | February 2025 | Allow | 8 | 1 | 0 | No | No |
| 18734602 | PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION | June 2024 | April 2025 | Allow | 10 | 0 | 1 | Yes | No |
| 18669211 | Composition for Relieving Sleep Disorder and its Application Method Thereof | May 2024 | December 2024 | Allow | 7 | 0 | 0 | Yes | No |
| 18667139 | HERBAL COMPOSITION PHY906 AND ITS USE IN CHEMOTHERAPY | May 2024 | January 2025 | Allow | 8 | 0 | 0 | Yes | No |
| 18665693 | Chemical Processes And Apparatuses For Extracting Organic Compounds From Biomass With Volatile Organic Compound Removal | May 2024 | August 2024 | Allow | 3 | 0 | 1 | No | No |
| 18661900 | COMPOSITION FOR TREATING BONE LOSS | May 2024 | July 2024 | Allow | 2 | 0 | 0 | No | No |
| 18659701 | COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF | May 2024 | May 2025 | Allow | 13 | 0 | 1 | Yes | No |
| 18655974 | STABILIZED COMPOSITIONS COMPRISING CANNABIDIOL | May 2024 | January 2025 | Allow | 9 | 0 | 1 | Yes | No |
| 18654377 | BARRIER GUARD TECHNOLOGY | May 2024 | December 2024 | Allow | 8 | 0 | 0 | Yes | No |
| 18651875 | HERBAL PRODUCTS AND METHODS FOR TETRAHYDROCANNABINOL (THC) DETOXIFICATION | May 2024 | February 2025 | Allow | 9 | 0 | 1 | No | No |
| 18650432 | CANNABIDIOL AND ACTIVE DELIVERY SYSTEMS | April 2024 | March 2025 | Allow | 10 | 0 | 0 | No | No |
| 18648175 | COMPOSITIONS AND METHODS FOR ALLEVIATING ADVERSE EFFECTS FROM RESPONSIBLE ALCOHOL CONSUMPTION | April 2024 | February 2025 | Allow | 10 | 2 | 1 | Yes | No |
| 18645314 | METHODS OF TREATING BLEEDING IN A SUBJECT TREATED WITH AN ANTIPLATELET AGENT | April 2024 | September 2024 | Allow | 5 | 1 | 0 | No | No |
| 18643408 | METHOD FOR INHIBITING ENZYME ACTIVITY USING BOSCIA SENEGALENSIS | April 2024 | September 2024 | Allow | 5 | 1 | 0 | No | No |
| 18639285 | METHODS OF TREATING ENDOMETRIOSIS AND OTHER NONCANCER GYNECOLOGICAL DISORDERS WITH HEMP EXTRACT | April 2024 | May 2025 | Allow | 13 | 1 | 1 | Yes | No |
| 18635597 | METHODS OF TREATING OVARIAN CANCER WITH HEMP EXTRACT | April 2024 | June 2025 | Allow | 14 | 1 | 0 | No | No |
| 18630703 | COMPOSITION FOR IMPROVING SKIN MOISTURIZATION OF COMPANION ANIMALS | April 2024 | July 2024 | Allow | 4 | 1 | 0 | No | No |
| 18626055 | GENETICALLY MODIFIED ZYMOMONAS MOBILIS TO UTILIZE INORGANIC N SOURCE, METHODS AND USES THEREOF | April 2024 | September 2024 | Allow | 5 | 0 | 1 | No | No |
| 18621062 | TRADITIONAL CHINESE MEDICINE COMPOUND FOR IMPROVING TESTICULAR DYSFUNCTION, PREPARATION METHOD AND APPLICATION THEREOF | March 2024 | October 2024 | Allow | 7 | 1 | 1 | Yes | No |
| 18605547 | NANOBANDAGE SOLUTION WITH FAIDHERBIA ALBIDA NANOPARTICLES AND NATURAL AND SYNTHETIC POLYMERS | March 2024 | November 2024 | Allow | 8 | 1 | 1 | No | No |
| 18603498 | ESSENTIAL OIL COMPOSITION AND PREPARATION METHOD THEREOF | March 2024 | October 2024 | Allow | 7 | 1 | 1 | No | No |
| 18597236 | COMPOSITIONS COMPRISING CANNABIS AND MUSHROOM EXTRACTS, AND USES THEREOF | March 2024 | December 2024 | Allow | 9 | 0 | 0 | No | No |
| 18594014 | PROCESS OF MANUFACTURING COMPOSITION FOR THE PREVENTION AND TREATMENT OF EARLY MORTALITY SYNDROME (EMS) SHRIMP | March 2024 | July 2024 | Allow | 4 | 1 | 1 | No | No |
| 18592551 | METHOD FOR PRODUCING A COMPLEX COMPOSITION OF TURKEY TAIL MUSHROOM EXTRACT- CHITOSAN | March 2024 | June 2024 | Allow | 3 | 1 | 1 | No | No |
| 18591599 | Composition Comprising Elderberry Extract as Effective Component for Preventing, Treating, or Alleviating Andropause Syndrome | February 2024 | April 2025 | Allow | 13 | 1 | 0 | No | No |
| 18683505 | LIQUID-LIQUID EXTRACTION OF PURIFIED PSYCHOACTIVE ALKALOID | February 2024 | September 2024 | Allow | 7 | 1 | 0 | No | No |
| 18436343 | TOPICAL SKIN COMPOSITIONS FOR TREATING ROSACEA AND SKIN REDNESS | February 2024 | December 2024 | Allow | 10 | 0 | 0 | No | No |
| 18436468 | FOODS TO PROMOTE BETTER HEALTH AND/OR TO MAINTAIN HOMEOSTAIS AND METHOD OF PRODUCTION THEREOF | February 2024 | December 2024 | Allow | 10 | 1 | 1 | Yes | No |
| 18434921 | GINSENOSIDE-CONTAINING COMPOSITION, DAILY-USE CHEMICAL AND USE THEREOF | February 2024 | May 2025 | Allow | 15 | 1 | 1 | No | No |
| 18433252 | CANNABIGEROL (CBG) PRODUCTS AND METHODS OF USE | February 2024 | December 2024 | Allow | 10 | 0 | 2 | No | No |
| 18432512 | TIME RELEASE SLEEP AID SYSTEM | February 2024 | May 2025 | Allow | 16 | 1 | 1 | Yes | No |
| 18429310 | SUSTAINABLE NANOCOMPOSITION FOR TREATMENT OF OSTEOPOROSIS | January 2024 | June 2024 | Allow | 5 | 0 | 1 | No | No |
| 18424092 | A METHOD OF PREVENTING CADMIUM-INDUCED RENAL TOXICITY USING A PLANT PRODUCT DERIVED FROM ACHILLEA MILLEFOLIUM L. | January 2024 | July 2024 | Allow | 6 | 1 | 0 | No | No |
| 18417543 | TOPICAL SKIN FORMULATIONS | January 2024 | October 2024 | Allow | 9 | 0 | 0 | No | No |
| 18415101 | Mesenchymal Stem Cell Derived Exosomes And Methods | January 2024 | June 2025 | Allow | 17 | 1 | 0 | No | No |
| 18411666 | STABILIZED OMEGA-3 OPHTHALMIC COMPOSITIONS | January 2024 | February 2025 | Abandon | 13 | 0 | 1 | No | No |
| 18410115 | De-constipation Method | January 2024 | August 2024 | Allow | 7 | 2 | 0 | No | No |
| 18410512 | PHYTOCHEMICAL/ NUTRACEUTICAL COMPOSITION FOR MULTIMODAL PROPHYLAXIS AGAINST AND TREATMENT OF VIRAL AND BACTERIAL INFECTION AND INFLAMMATION | January 2024 | May 2025 | Allow | 16 | 2 | 1 | Yes | No |
| 18407894 | ENU PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING NEUROPATHIC PAIN | January 2024 | December 2024 | Allow | 11 | 1 | 1 | No | No |
| 18406509 | METHOD FOR PRODUCING THERAPEUTIC AGENT FOR SKIN LESIONS, AND THERAPEUTIC AGENT FOR SKIN LESIONS | January 2024 | March 2025 | Allow | 15 | 1 | 0 | No | No |
| 18407411 | METHOD OF PREVENTING CADMIUM-INDUCED LIVER TOXICITY USING A PLANT PRODUCT DERIVED FROM ACHILLEA MILLEFOLIUM L. | January 2024 | August 2024 | Allow | 7 | 1 | 0 | No | No |
| 18401503 | PROTEIN BASED CANNABIS COMPOSITIONS | December 2023 | October 2024 | Allow | 10 | 0 | 0 | No | No |
| 18395180 | SEPARATION AND IDENTIFICATION OF MYRICETIN-3-OGALACTOSIDE FROM CASUARINA GLAUCA | December 2023 | October 2024 | Allow | 10 | 1 | 1 | No | No |
| 18394371 | TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | December 2023 | March 2025 | Allow | 14 | 1 | 1 | No | No |
| 18391502 | XENOGRAFT SOFT TISSUE IMPLANTS AND METHODS OF MAKING | December 2023 | March 2025 | Allow | 15 | 1 | 0 | No | No |
| 18391194 | METHOD OF TREATING ILLNESS USING LYOPHILIZED CAMEL URINE | December 2023 | September 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18544256 | METHOD FOR INHIBITING FUNGAL GROWTH USING PYROPIA YEZOENSIS | December 2023 | September 2024 | Allow | 9 | 1 | 1 | No | No |
| 18544077 | OIL EXTRACT OF CANNABIS AND METHOD FOR OBTAINING | December 2023 | May 2025 | Allow | 17 | 1 | 0 | No | No |
| 18538812 | BOTANICAL FORMULATIONS | December 2023 | December 2024 | Allow | 12 | 0 | 1 | Yes | No |
| 18537735 | SYNTHESIS OF A CARBON QUANTUM DOTS AND SILVER NANOPARTICLE COMPOSITION | December 2023 | May 2025 | Abandon | 18 | 2 | 1 | No | No |
| 18533558 | AQUEOUS WOUND HEALING FORMULATION | December 2023 | June 2025 | Abandon | 18 | 1 | 1 | Yes | No |
| 18529504 | COMPOSITION FOR TREATING BONE LOSS | December 2023 | April 2024 | Allow | 5 | 1 | 1 | Yes | No |
| 18521113 | COMPOSITIONS FOR SENSITIVE SKIN | November 2023 | October 2024 | Allow | 11 | 0 | 0 | No | No |
| 18520281 | COMPOSITION FOR SKIN-WHITENING OR PREVENTING OR IMPROVING SKIN WRINKLES COMPRISING GREEN TEA EXTRACT WHICH HAS MODIFIED AMOUNTS OF INGREDIENTS | November 2023 | September 2024 | Allow | 10 | 0 | 0 | No | No |
| 18517708 | EXTRACTS DERIVED FROM LASER-IRRADIATED RHIZOME OF CURCUMA LONGA HAVING ENHANCED ANTIMICROBIAL ACTIVITY | November 2023 | July 2024 | Allow | 8 | 2 | 1 | Yes | No |
| 18515789 | CRYSTALLINE FORMS OF PSILACETIN | November 2023 | August 2024 | Allow | 9 | 0 | 1 | Yes | No |
| 18514982 | Standardized psychoactive alkaloid extract composition | November 2023 | May 2024 | Allow | 6 | 1 | 1 | No | No |
| 18513032 | MIXTURE FOR TREATMENT OF RESPIRATORY ILLNESSES | November 2023 | December 2024 | Abandon | 13 | 1 | 1 | No | No |
| 18512157 | PEST CONTROL USING NATURAL PEST CONTROL AGENT BLENDS | November 2023 | March 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18509499 | COMPOSITION FOR PREVENTING OR TREATING GASTRITIS OR PEPTIC ULCER | November 2023 | March 2025 | Allow | 16 | 1 | 0 | No | No |
| 18388981 | USES OF CURCUMINOID COMPOSITIONS | November 2023 | September 2024 | Allow | 10 | 0 | 0 | No | No |
| 18559889 | USE OF EXTRACELLULAR VESICLES OF RHIZOMA DRYNARIAE IN PREPARATION OF MEDICINE FOR TREATING ORTHOPEDIC DISEASES | November 2023 | April 2025 | Allow | 17 | 1 | 0 | No | No |
| 18505309 | Topical NSAID Formulation with Improved Skin Absorption | November 2023 | February 2025 | Abandon | 15 | 1 | 1 | No | No |
| 18388167 | METHOD OF TREATMENT OF CANCERS | November 2023 | April 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18387298 | MEDICAL TREATMENT COMPOSITION, METHOD OF PREPARATION AND TREATMENT METHOD | November 2023 | June 2024 | Allow | 8 | 0 | 1 | Yes | No |
| 18384905 | Topical Traditional Chinese Medicine (TCM) Composition and Topical Preparation for Cervical Disease, and Preparation Methods Thereof | October 2023 | February 2024 | Allow | 3 | 0 | 1 | No | No |
| 18383606 | Compositions and Methods of Achieving Pain Relief | October 2023 | March 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18493997 | STABILIZED COMPOSITIONS COMPRISING CANNABIDIOL | October 2023 | April 2024 | Allow | 6 | 1 | 1 | Yes | No |
| 18382338 | METHODS FOR PREPARATION OF PLECTRANTHUS AMBOINICUS EXTRACTS | October 2023 | May 2025 | Allow | 19 | 1 | 1 | No | No |
| 18490143 | WATER-BASED CANNABINOID AND OPIOID COMPOSITIONS | October 2023 | August 2024 | Allow | 10 | 0 | 0 | No | No |
| 18381542 | MIXTURE OF CYANOBACTERIA, CHITOSAN, AND PLANT EXTRACTS FOR WOUND HEALING AND ELIMINATING PATHOGEN BACTERIA | October 2023 | August 2024 | Allow | 10 | 2 | 0 | No | No |
| 18381479 | MIXTURE OF CYANOBACTERIA, CHITOSAN, AND PLANT EXTRACTS FOR WOUND HEALING AND ELIMINATING PATHOGEN BACTERIA | October 2023 | May 2025 | Abandon | 19 | 4 | 0 | Yes | No |
| 18381439 | PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF THERAPEUTIC COMPOUNDS | October 2023 | April 2024 | Allow | 6 | 0 | 1 | Yes | No |
| 18381558 | BETA-ADRENERGIC AGONIST AND MUSCARINIC ANTAGONIST COMPOSITIONS AND METHODS OF USING | October 2023 | April 2024 | Allow | 6 | 1 | 1 | Yes | No |
| 18381023 | PHARMACEUTICAL COMPOSITION COMPRISING A FRACTION OF MELISSA OFFICINALIS LEAF EXTRACT | October 2023 | July 2024 | Allow | 9 | 1 | 0 | No | No |
| 18487399 | UVARIA GRANDIFLORA EXTRACT AS A BOTANICAL FUNGICIDE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | October 2023 | October 2024 | Abandon | 12 | 1 | 1 | No | No |
| 18379955 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TISSUE INJURY AND DISEASE | October 2023 | March 2025 | Allow | 17 | 1 | 0 | No | No |
| 18554058 | Acoustically Responsive Biomaterials | October 2023 | April 2025 | Allow | 19 | 1 | 2 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1655.
With a 23.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 26.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Art Unit 1655 is part of Group 1650 in Technology Center 1600. This art unit has examined 13,763 patent applications in our dataset, with an overall allowance rate of 55.4%. Applications typically reach final disposition in approximately 31 months.
Art Unit 1655's allowance rate of 55.4% places it in the 10% percentile among all USPTO art units. This art unit has a significantly lower allowance rate than most art units at the USPTO.
Applications in Art Unit 1655 receive an average of 1.70 office actions before reaching final disposition (in the 39% percentile). The median prosecution time is 31 months (in the 36% percentile).
When prosecuting applications in this art unit, consider the following:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.